Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
76°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acadia Pharmaceutica
(NQ:
ACAD
)
15.94
+0.26 (+1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Acadia Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
Next >
Recap: ACADIA Pharmaceuticals Q4 Earnings
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.
Via
InvestorPlace
Analyst Scoreboard: 12 Ratings For ACADIA Pharmaceuticals
January 24, 2024
Via
Benzinga
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Deep Dive Into ACADIA Pharmaceuticals Stock: Analyst Perspectives (13 Ratings)
December 29, 2023
Via
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
December 12, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
November 06, 2023
Via
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
October 10, 2023
Via
Benzinga
Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug
December 13, 2023
MSN Labs lost out in a summary judgement to knock off Acadia's Nuplazid.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
What's Going On With Acadia Pharmaceuticals Stock?
December 13, 2023
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares are trading higher Wednesday after the company won summary judgement in a patent suit regarding its Nuplazid drug. What To Know:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via
Benzinga
3 Biotech Stocks With the Strongest Clinical Pipelines
November 08, 2023
Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
Via
Benzinga
Why Acadia Pharmaceuticals Stock Is Rising Today
October 10, 2023
An analyst upgrade is sparking a rally in the drugmaker's shares today.
Via
The Motley Fool
2 Growth Stocks I'd Buy on the Dip
September 30, 2023
These two growth stocks could be worthwhile buy-and-holds.
Via
The Motley Fool
Analyst Ratings for ACADIA Pharmaceuticals
August 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Via
Benzinga
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?
August 22, 2023
This biotech stock has been on fire in 2023.
Via
The Motley Fool
Analyst Expectations for ACADIA Pharmaceuticals's Future
August 03, 2023
Via
Benzinga
ACADIA Pharmaceuticals's Earnings: A Preview
August 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
Via
Benzinga
Electronic Arts To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Tuesday
October 10, 2023
JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock from Neutral to Overweight. ACADIA Pharmaceuticals shares...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
2 Supercharged Growth Stocks Billionaires Can't Stop Buying
August 28, 2023
A top hedge fund has been steadily buying these two growth stocks in 2023.
Via
The Motley Fool
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
August 16, 2023
This small-cap biotech might be a hidden gem.
Via
The Motley Fool
JP Morgan Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
August 07, 2023
Via
Benzinga
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
July 14, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Friday. The Dow traded up 0.30% to 34,498.91 while the NASDAQ fell 0.36% to 14,087. The S&P...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.